Blockchain Registration Transaction Record

Redwood AI Joins Terry Fox Grant for AI Drug Development

Redwood AI joins Terry Fox grant to develop Onco-Innovations' SynoGraph AI platform, advancing AI-driven drug development for oncology.

This collaboration underscores the growing role of artificial intelligence in accelerating drug discovery and development. By combining causal AI with preclinical and real-world data, the project could lead to more accurate predictions of therapy performance in human trials, potentially reducing the time and cost of bringing new treatments to patients. For Redwood AI, this expands its life sciences applications and demonstrates the versatility of its technology beyond cybersecurity. For the broader industry, it highlights how AI and chemical modelling can work together to streamline research and improve success rates in oncology, ultimately benefiting patients and investors alike.